mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.6 |
mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.6 |
mRNA |
paclitaxel |
CCLE |
pan-cancer |
AAC |
0.025 |
0.6 |
mRNA |
BRD-K45681478 |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.6 |
mRNA |
ML203 |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
CHEMBL374350 |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
CIL70 |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.6 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |